We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 240.00 | 1.98% | 12,358.00 | 12,358.00 | 12,360.00 | 12,364.00 | 12,228.00 | 12,244.00 | 338,837 | 11:03:38 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 32.04 | 190.8B |
From May 2019 to May 2024
By Samantha Pearson
Brazilian health regulator Anvisa voted Sunday to approve the use of the country's first Covid-19 vaccines, China's CoronaVac and the shot developed by AstraZeneca PLC and Oxford University, raising spirits in a nation that is struggling to cope with a surge in infections.
(END) Dow Jones Newswires
January 17, 2021 13:38 ET (18:38 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Astrazeneca Chart |
1 Month Astrazeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
